VANGUARD GROUP INC - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 18 filers reported holding VIRIOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$193,175
-33.7%
208,883
-1.0%
0.00%
Q2 2023$291,175
+3709.2%
210,996
+914.5%
0.00%
Q1 2023$7,644
-78.2%
20,798
-86.0%
0.00%
Q4 2022$35,082
-61.9%
148,651
-38.5%
0.00%
Q3 2022$92,000
-91.0%
241,6660.0%0.00%
Q2 2022$1,022,000
-5.5%
241,6660.0%0.00%
Q1 2022$1,082,000
+42.9%
241,666
+63.4%
0.00%
Q4 2021$757,000
-3.2%
147,8660.0%0.00%
Q3 2021$782,000
-11.8%
147,866
+4.9%
0.00%
Q2 2021$887,000141,0110.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
McCollum Christoferson Group LLC 33,300$30,7960.01%
&PARTNERS 11,000$10,1730.01%
Virtu Financial LLC 27,322$250.00%
XTX Topco Ltd 14,441$13,3550.00%
RAYMOND JAMES & ASSOCIATES 30,000$27,7440.00%
WELLS FARGO & COMPANY/MN 124$1150.00%
NORTHERN TRUST CORP 24,035$22,2280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 11,482$10,6190.00%
GEODE CAPITAL MANAGEMENT, LLC 174,469$161,3750.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders